Celldex Therapeutics Announces Proposed Public Offering of Common Stock

Published December 4, 2013

Celldex Therapeutics Announces Proposed Public Offering of Common Stock
HAMPTON, N.J., Dec 03, 2013 (GLOBE NEWSWIRE via COMTEX) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that it is offering 6.5 million shares of its common stock in a proposed underwritten public offering. The offering is subject to … Read more on MarketWatch

Enteris BioPharma Forms Scientific Advisory Board to Enhance Leadership in …
Dr. Chernoff stated, "Working at one of the nation's forty-one NCI-designated Comprehensive Cancer Centers, I have made a career in cancer research and treatment with the goal of improving therapies in solid tumors. Among its many differentiating … Read more on PR Newswire (press release)